[DGX] Quest Diagnostics Incorporated

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical Specialities

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 92.41 Change: 0.61 (0.66%)
Ext. hours: Change: 0 (0%)

chart DGX

Refresh chart

Strongest Trends Summary For DGX

DGX is in the medium-term down -22% below S&P in 1 year. In the long-term up 88% in 12 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. It offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights; laboratory testing services for new drugs, vaccines, and medical devices; and risk assessment services for the life insurance industry. The company also develops, manufactures, and markets diagnostic products, including Simplexa molecular chemistries for testing infectious disease and hospital-acquired infections; HerpeSelect HSV serology; and DxSelect IFA and ELISA products for testing infectious diseases. In addition, it provides molecular diagnostic products in various segments, such as HIV-1 drug resistance testing under the ViroSeq brand name; and reproductive genetics and transplantation under the

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters-95.95% EPS Growth - Q/Q-97.76%
EPS Growth - Y/Y-46.52% Sales Growth - 4 Quarters -3.31% Sales Growth - Q/Q-2.34% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA4.83% ROE12.09% ROI6.04%
Current Ratio1.14 Quick Ratio1.09 Long Term Debt/Equity12.9 Debt Ratio0.49
Gross Margin37.58% Operating Margin13.32% Net Profit Margin6.81% Dividend Payout Ratio-44.83%
Dividend Yield
Fundamental Data
Cash From Financing Activities-246 M Cash From Investing Activities-123 M Cash From Operating Activities327 M Gross Profit747 M
Net Profit118 M Operating Profit301 M Total Assets9.72 B Total Current Assets1.53 B
Total Current Liabilities1.24 B Total Debt3.74 B Total Liabilities5.41 B Total Revenue1.93 B
Technical Data
High 52 week114.44 Low 52 week79.25 Last close87.19 Last change-0.69%
RSI47.59 Average true range1.98 Beta0.67 Volume278.29 K
Simple moving average 20 days-0.69% Simple moving average 50 days2.13% Simple moving average 200 days-12.16%
Performance Data
Performance Week-0.71% Performance Month1.86% Performance Quart-7.29% Performance Half-20.86%
Performance Year-12.71% Performance Year-to-date5.37% Volatility daily1.48% Volatility weekly3.31%
Volatility monthly6.78% Volatility yearly23.5% Relative Volume285.51% Average Volume1.42 M
New High New Low

News

2019-03-16 09:30:01 | Quest Diagnostics DGX Up 3.5% Since Last Earnings Report: Can It Continue?

2019-03-14 09:40:01 | Should Value Investors Pick Quest Diagnostics DGX Stock?

2019-03-12 10:25:31 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.

2019-03-11 23:17:52 | Oxford Immunotec Global PLC OXFD Q4 2018 Earnings Conference Call Transcript

2019-03-07 17:30:00 | Quest Diagnostics Prices $500 Million of Senior Notes

2019-03-07 12:16:09 | Quest Diagnostics Incorporated -- Moody's assigns Baa2 rating to Quest Diagnostics' notes offering

2019-03-07 11:28:00 | Quest Diagnostics To Speak At The Barclays Global Healthcare Conference

2019-03-05 07:35:12 | Quest Diagnostics Ties Up With RMC to Deliver Lab Services

2019-03-04 09:28:18 | Should Quest Diagnostics Be Disappointed With Their 64% Profit?

2019-03-01 16:30:00 | Quest Diagnostics Declares Quarterly Cash Dividend

2019-02-27 06:45:00 | RMC and Quest Diagnostics to Deliver High-Value, Innovative Lab Services

2019-02-22 10:44:03 | Quest Diagnostics Grows on Innovation Amid Reimbursement Woe

2019-02-22 07:25:00 | Analysis: Positioning to Benefit within Quest Diagnostics, Autodesk, Agios Pharmaceuticals, AMN Healthcare Services, Vistra Energy, and Helen of Troy — Research Highlights Growth, Revenue, and Consolidated Results

2019-02-21 16:48:30 | Quest Diagnostics Inc DGX Files 10-K for the Fiscal Year Ended on December 31, 2018

2019-02-20 06:45:00 | Quest Diagnostics Partners With Houston Healthcare to Deliver High-Value, Innovative Laboratory Services

2019-02-19 16:43:00 | Quest Diagnostics Elects Denise Morrison to Board of Directors

2019-02-19 11:42:50 | Edited Transcript of DGX earnings conference call or presentation 14-Feb-19 1:30pm GMT

2019-02-18 12:00:00 | Quest Diagnostics Names Gabrielle Wolfson Senior Vice President and Chief Information and Digital Officer

2019-02-18 08:43:13 | How Much Are Quest Diagnostics Incorporated NYSE:DGX Insiders Taking Off The Table?

2019-02-14 15:37:38 | Quest Diagnostics Inc DGX Q4 2018 Earnings Conference Call Transcript

2019-02-14 13:54:06 | Quest Diagnostics DGX Q4 Earnings in Line, Margins Down

2019-02-14 08:00:01 | Quest Diagnostics DGX Q4 Earnings Meet Estimates

2019-02-14 07:11:15 | Quest Diagnostics: 4Q Earnings Snapshot

2019-02-14 06:45:00 | Quest Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results; Provides Guidance For Full Year 2019

2019-02-13 17:20:00 | Quest Diagnostics Expected to Earn $1.37 a Share

2019-02-13 08:00:00 | Walmart’s Influence in the Healthcare Sector; Spreading Health and Wealth as Vendors Capitalize on Spending

2019-02-12 07:29:20 | Quest Diagnostics Reports Earnings in Recovery Mode

2019-02-11 16:01:00 | Quest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology Laboratories

2019-02-11 09:19:02 | Can M&A Activity Drive Quest Diagnostics DGX Q4 Earnings?

2019-02-08 08:01:28 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.

2019-02-07 10:31:03 | Earnings Preview: Quest Diagnostics DGX Q4 Earnings Expected to Decline

2019-01-31 07:25:00 | Investor Expectations to Drive Momentum within Old Republic International, Quest Diagnostics, Prudential Financial, The Mosaic, PACCAR, and NEXEO SOLUTIONS — Discovering Underlying Factors of Influence

2019-01-29 12:40:50 | Risk-Reward With Quest Diagnostics

2019-01-28 14:28:27 | One Factor To Consider Before Investing In Quest Diagnostics Incorporated NYSE:DGX

2019-01-25 09:21:46 | Is Silicon Valley the real villain in the Theranos story? A new documentary makes the case.

2019-01-24 16:48:09 | Quest Diagnostics CEO Steve Rusckowski speaks with Yahoo Finance at Davos 2019

2019-01-24 10:18:32 | Health care CEO: 'Most people don't understand the basic economics' of health care

2019-01-22 11:27:00 | Quest Diagnostics Named One of 2019 _World's Most Admired Companies_ by Fortune Magazine for Fourth Consecutive Year

2019-01-22 08:01:18 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.

2019-01-21 10:02:03 | Quest Diagnostics' Core Diagnostics Strong Amid Several Woes

2019-01-15 08:01:12 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.

2019-01-14 08:09:00 | More Adults Know Their Multidigit Wi-Fi Password Than Vital Health Information, Including Their Single-Letter Blood Type

2019-01-09 08:00:34 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.

2019-01-09 06:55:32 | Is Quest Diagnostics Incorporated’s NYSE:DGX 17% ROE Strong Compared To Its Industry?

2019-01-08 08:20:52 | Health care continues to grow: Quest Diagnostics CEO

2019-01-07 09:40:00 | Quest Diagnostics To Release Fourth Quarter And Full Year 2018 Financial Results On February 14

2019-01-02 17:27:00 | Quest Diagnostics To Speak At The 37th Annual J.P. Morgan Healthcare Conference

2018-12-24 08:14:01 | Quest Diagnostics DGX Divests India Business to Strand

2018-12-22 09:49:58 | Should You Investigate Quest Diagnostics Incorporated NYSE:DGX At US$81.70?

2018-12-21 12:30:00 | Quest Diagnostics Completes Sale of India Diagnostics Services Business to Strand Life Sciences